Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin

被引：4
|
作者：
Biselli, M
Lorenzini, S
Gramenzi, A
Andreone, P
Bernardi, M
Rossi, C
Grazi, GL
机构：
[1] Univ Bologna, Dipartimento Med Interna, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Radiol, I-40138 Bologna, Italy
[3] Univ Bologna, Dept Surg, I-40138 Bologna, Italy
来源：
TRANSPLANTATION | 2004年 / 78卷 / 06期
关键词：
D O I：
10.1097/01.tp.0000135566.33051.35
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：953 / 954
页数：2
相关论文
共 50 条
  • [31] Hepatitis C viral kinetics treated with ribavirin and interferon alpha-2b in patients with normal transaminases.
    Pena, R
    Munoz, S
    Suvannasankha, A
    DiGregorio, K
    Stein, L
    Gross, F
    Peikin, S
    Perez, O
    Benson, G
    Mushnick, A
    DeAngelo, C
    Goldfarb, J
    Rothstein, K
    Manzarbeitia, C
    Reich, D
    Kern, N
    HEPATOLOGY, 1998, 28 (04) : 286A - 286A
  • [32] Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    Crespo, M.
    Sauleda, S.
    Esteban, J. I.
    Juarez, A.
    Ribera, E.
    Andreu, A. L.
    Falco, V.
    Quer, J.
    Ocana, I.
    Ruiz, I.
    Buti, M.
    Pahissa, A.
    Esteban, R.
    Guardia, J.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (04) : 228 - 238
  • [33] Peg interferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive patients in Egypt
    Elwaki, M. R.
    Montasser, M. F.
    Mansour, M. A.
    Salman, T. A.
    El-Batanony, M. H.
    Helail, E. H.
    Shehata, K. O.
    Attallah, K. M.
    Madwar, M. A.
    LIVER INTERNATIONAL, 2006, 26 : 84 - 84
  • [34] Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection
    Takayama, Tetsuro
    Ebinuma, Hirotoshi
    Tada, Shinichiro
    Yamagishi, Yoshiyuki
    Wakabayashi, Kanji
    Ojiro, Keisuke
    Kanai, Takanori
    Saito, Hidetsugu
    Hibi, Toshifumi
    PLOS ONE, 2011, 6 (12):
  • [35] Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues - Reply
    Kamal, Sanaa
    Schardell, Michelle
    El Kamary, Samer
    Hashem, Mohamed
    Mansour, Hoda
    Ibrahim, Amany Sayed
    HEPATOLOGY, 2008, 47 (05) : 1793 - 1794
  • [36] Reduction of hepatocellular carcinoma recurrence by pegylated interferon alpha-2b plus ribavirin treatment for chronic hepatitis C patients
    Furusyo, N.
    Murata, M.
    Ogawa, E.
    Nomura, H.
    Hayashi, J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S130 - S130
  • [37] Combination pegylated interferon alpha-2b and ribavirin in transplant patients with recurrent hepatitis C infection: A preliminary report.
    Vargas, HE
    Rosati, MJ
    Douglas, DD
    Harrison, ME
    Mulligan, DC
    Moss, AA
    Rakela, J
    Balan, V
    HEPATOLOGY, 2001, 34 (04) : 407A - 407A
  • [38] Interferon alpha-2b and ribavirin for interferon monotherapy non-responders.
    Herrine, SK
    Conn, MI
    Jefferson, T
    Greenfield, SM
    Shaw, EW
    Thornton, JJ
    Weinberg, DS
    HEPATOLOGY, 1999, 30 (04) : 370A - 370A
  • [39] Safety and Efficacy of Combined Treatment with Pegylated Interferon Alpha-2b and Ribavirin for HCV Genotype 4 in Children
    El-Karaksy, Hanaa M.
    Mogahed, Engy A.
    El-Raziky, Mona S.
    Saleh, Doaa
    Besheer, Mahmoud
    Mubarak, Samah
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (01): : 1 - 8
  • [40] Comparative Effects of Interferon Alpha-2b and Pegylated Interferon Alpha-2b on Menstrual Cycles and Ovarian Hormones in Cynomolgus Monkeys
    Enright, Brian P.
    Compton, David R.
    Collins, Nathaniel
    Davis, Thomas
    McIntyre, Barry S.
    BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2009, 86 (01) : 29 - 39
12345